Random Peptide Array for Antibody Epitope Mapping
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for monoclonal antibody epitope mapping and profiling are costly and lack a universal, efficient platform for screening, requiring costly synthesis or enrichment steps.
Innovation Solution
A method involving contacting a monoclonal antibody with a random peptide array to identify binding peptides, deriving peptide sequences, and identifying conserved motifs to determine epitopes, using immunofluorescence assays and sequence alignment to characterize antibody binding specificity and specificity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If standard methods (peptide tiling, phage display, mRNA display) are used for epitope mapping, then epitope identification accuracy is improved, but cost and process complexity increase significantly
Solution Approach 1:
The patent employs disposable peptide arrays with randomly generated peptides that are synthesized in a cost-effective manner. These arrays are used once for screening monoclonal antibodies and then discarded, eliminating the need for expensive, complex enrichment steps required by traditional methods like phage display. The random peptide sequences are generated computationally and synthesized directly on the array surface, providing a simple, low-cost platform for epitope mapping.
2Measurement precision
If standard methods (peptide tiling, phage display, mRNA display) are used for epitope mapping, then epitope identification accuracy is improved, but synthesis cost increases
Solution Approach 1:
The patent uses cost-effective random peptide arrays where peptides are synthesized directly on the array surface using simple chemical synthesis methods. This eliminates the need for expensive in vitro transcription and translation systems required by mRNA display or the complex phage/bacteria enrichment processes. The random peptide library is generated computationally and synthesized in a single step, providing accurate epitope mapping at a fraction of the cost of traditional methods.
Solution Approach 2:
The patent creates a computational model of the peptide library and uses in silico screening to predict which peptides will bind to the monoclonal antibody. This computational copying and screening approach reduces the need for expensive physical synthesis and experimental testing of all possible peptides, allowing accurate epitope identification with minimal material consumption and cost.
3Productivity
If random peptide arrays are used for high-throughput screening, then screening efficiency is improved, but data analysis complexity increases
Solution Approach 1:
The patent introduces computational algorithms as an intermediary between the random peptide array screening and the final epitope identification. These algorithms automatically analyze the binding data, identify conserved motifs among bound peptides, and predict the epitope sequence. This computational mediator handles the complexity of analyzing thousands of random peptide sequences, transforming the high-throughput screening data into actionable epitope information without requiring manual analysis of each peptide sequence.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables high-throughput, cost-effective characterization of monoclonal antibody binding sites and epitope mapping, facilitating the selection of suitable therapeutic candidates.
Implementation Method 1
contacting a sample comprising a monoclonal antibody having unknown specificity for an antigen of interest to a plurality of randomly generated peptides immobilized on a support; selecting for peptides of the plurality that bind to the antibody
Implementation Method 2
Screening of the selected peptides for those that bind most strongly to the antibody can comprise an immunofluorescence assay
Data Source
AI summary
Methods for antibody profiling and epitope mapping are provided herein. More particularly, methods for screening and mapping epitopes of candidate antibodies and protein target identification are provided herein.